| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |